This article provides a comprehensive overview of liquid biopsy and circulating tumor DNA (ctDNA) analysis, tailored for researchers, scientists, and drug development professionals.
This comprehensive review explores the pivotal roles of oncogenes and tumor suppressor genes in cancer pathogenesis, tracing their discovery from foundational theories like Knudson's two-hit hypothesis to contemporary multi-omics approaches.
This article provides a comprehensive guide to next-generation sequencing (NGS) protocols for tumor profiling, tailored for researchers, scientists, and drug development professionals.
This article synthesizes current evidence and strategies for identifying candidates for hereditary cancer genetic testing, a critical step in precision oncology that remains significantly underutilized.
This article provides researchers, scientists, and drug development professionals with a systematic framework for understanding the classification of somatic variants in cancer.
This article provides a comprehensive analysis of the mechanisms by which somatic mutations drive tumor initiation and progression, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of fundamental cancer genetics concepts and modern terminology, tailored for researchers and drug development professionals.
This article comprehensively examines the expanding role of germline genetic variants in cancer predisposition, addressing key insights for researchers and drug development professionals.
This article provides a comprehensive overview of hereditary cancer syndromes (HCS) for researchers and drug development professionals.
This article provides a comprehensive overview of the fundamental principles and evolving landscape of molecular diagnostics in oncology, tailored for researchers, scientists, and drug development professionals.